ArticleCardiovascular diabetology2022

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics.

Gloria Cinquegrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.